Concurrent Xeloda and Radiotherapy for Bone Metastases
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief.
Primary Objective:
- To determine the frequency of pain relief for the proposed regimen.
Secondary Objective(s):
- To determine the duration of pain relief and narcotic relief for the proposed regimen.
- To determine the frequency of narcotic relief for the proposed regimen.
- To determine the toxicity of concurrent UFT and radiotherapy in patients with bone
metastases.